Artivion Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Artivion Inc in the first quarter 2026?
Artivion Inc achieved a return on average equity (ROE) of 2.66 % in its first quarter 2026 a new company high.

While the company's net income was fading, Artivion Inc was able to improve its ROE compared to the fourth quarter 2025.

Within the Medical Equipment & Supplies industry 56 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2025 from 799 to 2096.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Equity Change	53.09 %	62.29 %	43.96 %	42.31 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	12	10	-9	-18	-21
Return On Equity (TTM)	2.66 %	2.44 %	-2.56 %	-5.54 %	-7.31 %
AORT's Total Ranking	# 2096	# 799	# 2234	# 1714	# 2303
Equity (TTM) in Millions	450	448	439	420	294
Seq. Equity Change	0.5 %	2.17 %	4.48 %	42.7 %	6.54 %
Seq. Net Income Change	-41.59 %	-62.69 %	383.42 %	-	-

Back to AORT Management Effectiveness >> AORT's 5 Years Annual ROE >> Compare AORT ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 57
Sector	# 176
Overall	# 2096

Return On Equity Statistics
High	Average	Low
2.66 %	-4.94 %	-11 %
(Mar 31 2026)		(Dec 31 2023)

AORT Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	448	276	282	284	301
Y / Y Equity Change	62.29 %	-1.98 %	-0.9 %	-5.45 %	5.26 %
Net Income in Millions	10	-13	-31	-19	-15
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	2.18 %	-4.84 %	-10.89 %	-6.75 %	-4.93 %

Back to AORT Management Effectiveness >> AORT's 5 Years Annual ROE >> Compare AORT ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 2.18 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
AORT's' Return on Equity at Yahoo Finance
AORT's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for AORT's Competitors
Subscribers only: Roe for Artivion Inc 's Suppliers
Subscribers only: Return On Equity for AORT's Customers

Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector	ROE
Corcept Therapeutics Inc	7.31 %
Veracyte Inc	6.86 %
Vericel Corporation	6.41 %
Vaso Corporation	6.23 %
Zimmer Biomet Holdings Inc	6.00 %
Bio techne Corp	5.56 %
Conmed Corporation	5.40 %
National Vision Holdings Inc	5.36 %
Fonar Corporation	5.26 %
Becton Dickinson And Company	4.53 %
Biomarin Pharmaceutical Inc	4.41 %
Organon and Co	3.89 %
Xtant Medical Holdings Inc	3.68 %
Privia Health Group Inc	3.54 %
Revvity Inc	3.26 %
Surgery Partners Inc	3.10 %
The Cooper Companies Inc	2.85 %
Artivion Inc	2.66 %
Repligen Corp	2.46 %
Bio rad Laboratories Inc	2.40 %
Icu Medical Inc	2.19 %
Envista Holdings Corporation	2.18 %
Radnet Inc	1.70 %
Lifestance Health Group Inc	1.56 %
Castle Biosciences Inc	1.04 %
Talkspace Inc	1.03 %
Pacira Biosciences inc	0.73 %
Jazz Pharmaceuticals Plc	0.71 %
Therapeuticsmd Inc	0.66 %

Date modified: 2026-09-26T07:26:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.